A Multicenter Comparative Trial of Three-Day Norfloxacin vs Ten-Day Sulfamethoxazole and Trimethoprim for the Treatment of Uncomplicated Urinary Tract Infections

Archives of Internal Medicine

Volumn 147, Issue 10, 1987, Pages 1760-1762

  Stein, Gary E ^a   Mummaw, Nancy ^a   Goldstein, Ellie J C ^b   Boyko, Edward J ^c   Reller, L Barth ^c   Kurtz, Terrance O ^d   Miller, Kenneth ^e   Cox, Clair E ^f  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b R M ALDEN RESEARCH LABORATORY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Associated Medical Clinic ^*  (United States)

^e ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORFLOXACIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

DRUG EFFICACY; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; PYURIA; THERAPY; TREATMENT; URINARY TRACT; URINARY TRACT INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMAN; MALE; MIDDLE AGE; NORFLOXACIN; PYURIA; RANDOM ALLOCATION; SULFAMETHOXAZOLE; SUPPORT, NON-U.S. GOV'T; TRIMETHOPRIM; URINARY TRACT INFECTIONS;

EID: 0023226230     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1987.00370100074013     Document Type: Article

References (29)

1. Khan MY, Gruninger RP, Nelson SM, et al: Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates. Antimicrob Agents Chemother 1982;21: 848-851.
2. Norrby SD, Jonsson M: Antibacterial activity of norfloxacin. Antimicrob Agents Chemother 1983;23:15-18.
3. Haase D, Urias B, Harding G, et al: Comparative in vitro activity of norfloxacin against urinary tract pathogens. Eur J Clin Microbiol 1983;2: 235-241.
4. Leigh DA, Smith EC, Marriner J: Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients. J Antimicrob Chemother 1984;13(suppl B):79-83.
5. Goldstein EJC, Alpert ML, Ginsberg BP: Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections. Antimicrob Agents Chemother 1985;27: 422-423.
6. Marble DA, Bosso JA: Norfloxacin: A quinolone antibiotic. Drug Intell Clin Pharm 1986;20:261-266.
7. Giamarellou H, Tsaragarahis J, Petrikkos G, et al: Norfloxacin vs cotrimoxazole in the treatment of lower urinary tract infections. Eur J Clin Microbiol 1983;2:266-269.
8. Haase DA, Harding GKM, Thomson MJ, et al: Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora. Antimicrob Agents Chemother 1984;26:481-484.
9. Sabbaj J, Hoagland VL, Shih WJ: Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections. Antimicrob Agents Chemother 1985;27:297-301.
10. The Urinary Tract Infection Group: Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. J Infect Dis 1987;155:170-177.
11. Watt B, Chait I, Kelsey MC, et al: Norfloxacin vs cotrimoxazole in the treatment of uncomplicated urinary tract infections: A multicenter trial. J Antimicrob Chemother 1984;13(suppl B):89-94.
12. Swanson BN, Boppana VK, Vlasses PH, et al: Norfloxacin disposition after sequentially increasing oral doses. Antimicrob Agents Chemother 1983;23:284-288.
13. Bauer AW, Kirby MM, Sherris JC, et al: Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 1966;45: 593-596.
14. Shungu DL, Tutlane V, Gadebusch HH: Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacin. J Clin Microbiol 1983;18:988-991.
15. Schultz HJ, McCaffrey LA, Keys TF, et al: Acute cystitis: A prospective study of laboratory tests and duration of therapy. Mayo Clin Proc 1984;59:391-397.
16. Simon R: Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986;105:429-435.
17. Wolfson JS, Hooper DC: The fluoroquinolones: Structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 1985;28:581-586.
18. Hooper DC, Wolfson JS: The fluoroquinolones: Pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother 1985;28: 716-721.
19. Downs J, Andriole VT, Ryan JL: In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1982;21:670-672.
20. Hooper DC, Wolfson JS, Souza KS, et al: Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob Agents Chemother 1986;29:639-644.
21. Bergeron MG, Thabet M, Ray R, et al: Norfloxacin penetration into human renal and prostatic tissues. Antimicrob Agents Chemother 1985;28: 349-350.
22. Greenberg RN, Sanders CV, Lewis AC, et al: Single-dose cefaclor therapy for urinary tract infection. Am J Med 1981;71:841-845.
23. Hooton TM, Running K, Stamm WE: Single-dose therapy for cystitis in women. JAMA 1985;253:387-390.
24. Cordenas J, Quinn EL, Rooker G, et al: Single-dose cephalexin therapy for acute bacterial urinary tract infections and acute urethral syndrome with bladder bacteriuria. Antimicrob Agents Chemother 1986;29: 383-385.
25. Fihn SD: Single-dose antimicrobial therapy for urinary tract infections: ‘Less is more’? or ‘reductio and absurdum’? J Gen Intern Med 1986;1:62-65.
26. Philbrick JT, Bracikowski JP: Single-dose antibiotic treatment for uncomplicated urinary tract infections. Arch Intern Med 1985;145: 1672-1678.
27. Fair WR, Crane DB, Peterson LJ, et al: Three-day treatment of urinary tract infections. J Urol 1980;123:717-721.
28. Charlton CAC, Crowther A, Davies JG, et al: Three-day and ten-day chemotherapy for urinary tract infections in general practice. Br Med J 1976;1:124-126.
29. Gossius G, Vorland L: A randomized comparison of single-dose vs three-day and ten-day therapy for trimethoprim-sulfamethoxazole for acute cystitis in women. Scand J Infect Dis 1984;16:373-379.